Dr. Silverstein answers: 'What If More Cancer is Found During Lumpectomy?' — -- Question: What will the surgeon do if more cancer is evident during lumpectomy surgery? Answer: If more cancer is ...

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...

INSITE Trial included more than 400 patients at 14 leading academic and community cancer centers Intracavity visualization system uses fluorescence imaging designed to identify residual cancer and ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today ...

Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...

Grace Eisenhart relies on her faith to bring her peace as she prepares to battle breast cancer after several major illnesses ...

Breast cancer surgery no longer always means large scars or a drastically different body. Advances such as minimal-scar ...

Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and Drug ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

In a clinical trial of 406 patients, Mass General Cancer Center investigators found that real-time imaging using a fluorescent agent had a favorable impact for 1 in 10 patients, with potential to ...

Potter helps breast cancer patients rebuild their bodies through reconstructive surgery after mastectomy or lumpectomy.

Lumpectomy is the gold standard for breast cancer surgery, says Kirstyn E. Brownson, MD, a surgical breast oncologist at Huntsman Cancer Institute. We asked Dr. Brownson to explain what a lumpectomy ...